Google spinoff Isomorphic Labs is in a race to shake up the long, painful road to cancer-beating drugs
Source: Business Insider ·
Isomorphic Labs, the brainchild of Nobel Laureate Demis Hassabis, has an ambitious mission even by the standards of AI labs: curing cancer.
From the source
Isomorphic Labs president Max Jaderberg believes that in five years' time, all drugs will be designed by AI.Jillian Edelstein for BIIn a cavernous office in London's AI hub, a group of researchers is preparing to do battle with humanity's oldest enemy.Isomorphic Labs, a spinoff of Google DeepMind and the brainchild of AI pioneer Demis Hassabis, has an ambitious mission even by the standards of other AI labs: using AI to create drugs that could cure cancer and make disease a thing of the past.Max Jaderberg, Isomorphic's president and the person running day-to-day operations at the company under Hassabis' aegis as CEO, knows it's a lofty goal. Even so, he is unfazed."It's a ridiculous statement, but we really say it with a straight face," said Jaderberg, 36, who spoke to Business Insider in an exclusive interview in September. He added that the rate at which Isomorphic employees were coming to him with internal breakthroughs had accelerated from monthly to weekly in the past three…
BestAIBroker analysis
- Finance-aware sentiment: slightly positive (+0.30 on a -1 to +1 scale).
- Event classification: OTHER.
- Market importance score: 30/100, weighting entity relevance, source credibility, multi-outlet coverage and recency.
- Symbols referenced: AI.